Yes they have had a good number of non-positive surprises delays and such . . . but they have had some very positive surprises too: * Purchase of Flaskworks for full automation and a 10X or more volume manufacturing improvement * Selling the site in England to help fund the company without another toxic stock sale * Change the end points to leverage historical data before lockdown which enable them to continue to pursue approval with this trial
If I think hard about I am sure there are more but these are some notable ones!!!